IART Share Price

Open 79.03 Change Price %
High 79.86 1 Day 0.56 0.71
Low 77.82 1 Week 3.34 4.41
Close 79.12 1 Month -0.81 -1.01
Volume 432110 1 Year 14.91 23.22
52 Week High 88.86
52 Week Low 0.00
IART Important Levels
Resistance 2 81.01
Resistance 1 80.23
Pivot 78.93
Support 1 78.01
Support 2 77.23
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ETRM 0.07 0.00%
AAPL 113.86 1.55%
AAPL 113.86 1.55%
More..
NASDAQ USA Top Gainers Stocks
HTCO 11.00 62.96%
LOCM 0.09 50.00%
OPXA 1.21 40.70%
QKLS 0.18 38.46%
ZAZA 0.08 33.33%
MOSY 0.46 31.43%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PPHM 0.40 25.00%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
BGMD 0.05 -37.50%
More..

Integra LifeSciences Holdings Corporation (NASDAQ: IART)

IART Technical Analysis 1.5
As on 9th Dec 2016 IART Share Price closed @ 79.12 and we RECOMMEND Buy for LONG-TERM with Stoploss of 74.53 & Sell for SHORT-TERM with Stoploss of 80.92 we also expect STOCK to react on Following IMPORTANT LEVELS.
IART Target for December
1st Target up-side 85.01
2nd Target up-side 87.96
3rd Target up-side 90.91
1st Target down-side 76.59
2nd Target down-side 73.64
3rd Target down-side 70.69
IART Other Details
Segment EQ
Market Capital 1070191616.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.integralife.com
IART Address
IART
311 Enterprise Drive
Plainsboro, NJ 08536
United States
Phone: 609-275-0500
Fax: 609-275-5363
Interactive Technical Analysis Chart Integra LifeSciences Holdings Corporation ( IART NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Integra LifeSciences Holdings Corporation
IART Business Profile
Integra LifeSciences Holdings Corporation (Integra) is an integrated medical technology company. Integra offers solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. It has developed numerous product lines for applications ranging from burn and deep tissue wounds to regeneration of dura mater in the brain and repair of nerve and tendon. It operates in five business segments: U.S. Neurosurgery, U.S. Extremities, U.S. Instruments, U.S. Spine and Other, and International. The International segment sells similar products to Europe, Middle East and Africa, and Central/South America, Asia-Pacific and Canada. On April 30, 2013, it released its Hollywood VI intervertebral body fusion device (IBD) system. In January 2014, Integra LifeSciences Holdings Corp completed the acquisition of DuraSeal product lines from Covidien. In January 2014, Covidien PLC completed the sale of its Confluent Surgical product line to the Company.